RYTM Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

$21.25  -0.42 (-1.94%)
As of 04/09/2021 15:59:52 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/05/2017
Outstanding shares:  50,181,164
Average volume:  520,357
Market cap:   $1,067,353,358
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    76243J105
ISIN:        US76243J1051
Sedol:      BF2YWG4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.65
PS ratio:   0.00
Return on equity:   -80.46%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy